(155 days)
Not Found
No
The description focuses on electromagnetic tracking, CT-based modeling, and respiratory gating, with no mention of AI or ML algorithms for image analysis, navigation, or other functions.
No.
The ig4 System is a stereotactic accessory used for guiding interventional instruments and endoscopic tools; it does not directly treat or cure a disease but aids in precise navigation during procedures.
No
This device is a surgical navigation system, not a diagnostic device. It aids in guiding interventional instruments and endoscopic tools within the body, utilizing pre-existing CT images, rather than diagnosing a condition itself.
No
The device description explicitly lists multiple hardware components including an EM tracking accessory, a patient referencing system, an EM field generator and tracking system, a computer system, and a pulmonary planning workstation.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Function: The ig4™ Image Guided System is a stereotactic accessory used during clinical interventions. It helps physicians navigate instruments within the body based on pre-operative CT scans and real-time tracking. It does not analyze or process biological specimens in vitro.
- Intended Use: The intended use clearly states it's for displaying and guiding instruments within the patient's body during procedures like biopsies, aspirations, ablations, and endoscopic bronchoscopy.
- Device Description: The description focuses on the hardware and software used for tracking and navigation within the body, not for analyzing biological samples.
Therefore, the ig4™ Image Guided System falls under the category of a surgical or interventional guidance system, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The ig4™ Image Guided System is a stereotactic accessory for Computed Tomography (CT) and endoscopic bronchoscope systems. The ig4 System is indicated for displaying:
- . An interventional instrument such as a biopsy needle, an aspiration needle, or ablation needle on a computer monitor that also displays a CT-based model of the target organ(s).
- . Images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires, in the pulmonary tract.
The ig4™ System compensates for the patient's respiratory phases.
The ig4™ System is intended for use in clinical interventions and for anatomical structures where computed tomography and/or endoscopic bronchoscopy are currently used for visualizing such procedures.
Product codes (comma separated list FDA assigned to the subject device)
JAK, KTI, LLZ
Device Description
The ig4™ EndoBronchial is an accessory for a CT System that utilizes electromagnetic tracking technology to locate and navigate endoscopic tools, catheters and guidewires relative to a CTbased model of the tracheobronchial tree. Due to system use to locate structures in soft tissue, the system incorporates a method of gating the location information on soft tissue to the patient's respiration. The ig4™ System consists of an EM tracking accessory, a patient referencing system, an EM field generator and tracking system, software, a computer system, and a pulmonary planning workstation. The EM tracking accessory consists of a navigation guidewire and may include additional navigated endoscopic tools.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Computed Tomography (CT)
Anatomical Site
Tracheobronchial tree (pulmonary tract), lungs, target organ(s)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physician / Clinical interventions
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench testing on a static phantom and animal testing were completed to demonstrate navigation accuracy. Additionally, biological testing was completed on the EM navigation accessory to demonstrate that there are no biocompatibility issues. As required by Veran Medical Technologies design control processes and risk analysis, all verification and validation activities have been completed by designated individuals and have demonstrated the safety and effectiveness of the device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
510(k) Summarv Veran Medical Technologies Traditional 510(k) ig4™ EndoBronchial
Date Prepared:
6/25/09
DEC - 2 2009
510(k) Applicant:
Veran Medical Technologies, Inc. 5743 West Park Avenue St. Louis, MO 63110 Telephone: (314) 659-8500 Fax: (314) 659-8560
Scott Wrightstone Contact:
Device Information:
ig4™ EndoBronchial Trade Name: Common Name: CT stereotactic accessory . Classification Name: Computed Tomography X-ray System Classification Code: JAK
Equivalent Legally-Marketed Devices:
ig4TM Image Guided System (K060903) superDimension inReach System (K081379)
Device Description:
The ig4™ EndoBronchial is an accessory for a CT System that utilizes electromagnetic tracking technology to locate and navigate endoscopic tools, catheters and guidewires relative to a CTbased model of the tracheobronchial tree. Due to system use to locate structures in soft tissue, the system incorporates a method of gating the location information on soft tissue to the patient's respiration. The ig4™ System consists of an EM tracking accessory, a patient referencing system, an EM field generator and tracking system, software, a computer system, and a pulmonary planning workstation. The EM tracking accessory consists of a navigation guidewire and may include additional navigated endoscopic tools.
Intended Use:
The ig4™ Image Guided System is a stereotactic accessory for Computed Tomography (CT) and endoscopic bronchoscope Systems. The ig4 System is indicated for displaying:
- An interventional instrument such as a biopsy needle, an aspiration needle, or ablation . needle on a computer monitor that also displays a CT-based model of the target organ(s).
- . A CT-based model of the lungs and images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires in the pulmonary tract.
1
The ig4TM System compensates for the patient's respiratory phases.
The ig4™ System is intended for use in clinical interventions and for anatomical structures where computed tomography and/or endoscopic bronchoscopy are currently used for visualizing such procedures.
Substantial Equivalence:
The primary difference between the ig4™ EndoBronchial and the ig4™ Image Guided System is that the bronchoscopic application is indicated for endobronchial navigation of endoscopic tools, catheters and guidewires rather than percutaneous navigation of interventional instruments.
The main differences between the ig4TM EndoBronchial and the inReach System is that the ig4™ EndoBronchial automatically registers the patient location to the CT-based model via the use of reference points, and compensates for the effects of respiration on soft tissue locations by gating the navigation displays to the point in the respiratory cycle where the CT-scans were acquired.
Dissimilarities between the ig4™ EndoBronchial and the predicate devices do not affect the safety or effectiveness of this device.
Performance Data:
Bench testing on a static phantom and animal testing were completed to demonstrate navigation accuracy. Additionally, biological testing was completed on the EM navigation accessory to demonstrate that there are no biocompatibility issues. As required by Veran Medical Technologies design control processes and risk analysis, all verification and validation activities have been completed by designated individuals and have demonstrated the safety and effectiveness of the device.
Clinical Data:
Clinical tests were not required to demonstrate the safety and effectiveness of the device.
Conclusion:
The information provided in this 510(k) notification supports that the ig4™ EndoBronchial was shown to be substantially equivalent to the inReach System (K081379) for its intended use of navigating endoscopic tools, catheters and guidewires in the pulmonary tract and to the ig4TM Image Guided System (K060903) in automatic 3D registration to a CT-based model of the lungs and navigation of instruments.
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus. The logo is black and white.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
DEC - 2 2009
Mr. Scott Wrightstone QA/RA Manager Veran Medical Technologies, Inc. 5743 West Park Avenue ST LOUIS MO 63110
Re: K091934
Trade/Device Name: ig4TM EndoBronchial Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK, KTI, and LLZ Dated: November 14, 2009 Received: November 17, 2009
Dear Mr. Wrightstone:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications) for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2 -
Enclosure
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Janine M. Morris
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
4
SECTION 4 - Indications for Use
510(k) Number: K091934
Device Name: ig4™ EndoBronchial ·
Indications for Use:
The ig4™ Image Guided System is a stereotactic accessory for Computed Tomography (CT) and endoscopic bronchoscope systems. The ig4 System is indicated for displaying:
- . An interventional instrument such as a biopsy needle, an aspiration needle, or ablation needle on a computer monitor that also displays a CT-based model of the target organ(s).
- . Images of the tracheobronchial tree to aid a physician in guiding endoscopic tools, catheters or guidewires, in the pulmonary tract.
The ig4™ System compensates for the patient's respiratory phases.
The ig4™ System is intended for use in clinical interventions and for anatomical structures where computed tomography and/or endoscopic bronchoscopy are currently used for visualizing such procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (Part 21 CFR 801 Subpart C)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Aonni mrz
(Division Sign-Off)
Division of Reproductive, Abdominal, and Radiological Device 510(k) Number
Page of